Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.


Explore the complexities of decentralized clinical trials (DCTs) in the Asia Pacific (APAC) Region with our in-depth whitepaper. Dive into the region-specific challenges, including regulatory nuances, patient diversity, technological infrastructure, and cultural influences. Find actionable recommendations and best practices for stakeholders involved in DCTs to drive successful trial execution in this dynamic and diverse landscape.
Unlock the potential of DCTs in APAC.
For more information, contact us.
Authors:
JÉRÔME ARMELLINI, Asia Head of Clinical Development & Operations Strategy, IQVIA
LI FERN YONG, Asia Decentralized Clinical Trial Deployment Lead, IQVIA
ANGÉLIQUE GRECO, APAC Clinical Project Manager, Project leadership, IQVIA
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.